Summary : Amgen (NASDAQ:AMGN) and Plexium, Inc. (Plexium) today announced an exclusive, worldwide, multi-year research collaboration and license agreement to identify novel…
company
-
-
AgrochemicalsPharma Science & Research
The key to a powerful antibiotic’s formation now clear
by adminby adminSynopsis : A powerful class of antibiotics called carbapenems can circumvent antibiotic resistance thanks to a particular chain of atoms in their…
-
Pharma Science & Research
Current COVID-19 vaccines induce robust cellular immunity against Omicron variant
by adminby adminA highly mutated version of SARS-CoV-2, the virus that causes COVID-19, the Omicron variant has been shown to cause breakthrough infections among…
-
Synopsis : The U.S. Food and Drug Administration has approved three applications for first generics of Gilenya (fingolimod) capsules for the treatment…
-
The prior authorization process often involves complex transactions and increases the burden not only on physicians and pharmacies, but can also impact…
-
AgrochemicalsGlobal MarketGsk
Milestone Cabenuva Approval Cuts Antiretroviral Dosing by Half
by adminby adminSynopsis : ViiV Healthcare’s HIV treatment Cabenuva has been approved by the U.S. Food and Drug Administration for use every two months,…
-
Synopsis :: -ImmunityBio shared positive results from the clinical trial of its IL-15 superagonist Anktiva (N-803) to treat people living with human…
-
Summary : Panacea Biotec Pharma is a subsidiary of vaccine maker Panacea Biotec; its domestic biz had a turnover of Rs 219…
-
AgrochemicalsMadrigal Pharmaceuticals
Dominic F. Labriola Joins Madrigal Pharmaceuticals as Chief Data and Analytics Officer
by adminby adminSynopsis : Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a clinical-stage biopharmaceutical company pursuing novel therapeutics for fatty liver diseases, announced today that Dr. Dominic F.…
-
RegulatoryU.S FDA
Positive Phase III Data Lifts Madrigal, Hopes for an Effective NASH Treatment
by adminby adminSynopsis : Shares of Madrigal Pharmaceuticals went up in premarket trading after the company announced positive topline data from its Phase III…